Amgen Inc (AMGN)

AMGN (NASDAQ:Drugs)
$115.46
pos +0.00
+0.00%
Today's Range: 115.02 - 117.19 | AMGN Avg Daily Volume: 3,767,300
Last Update: 04/17/14 - 3:59 PM EDT
Volume: 0
YTD Performance: 1.21%
Open: $0.00
Previous Close: $115.54
52 Week Range: $94.15 - $128.96
Oustanding Shares: 755,007,290
Market Cap: 87,344,022,042
6-Month Chart
TheStreet Ratings Grade for AMGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 8 9
Moderate Buy 0 0 0 0
Hold 11 12 12 12
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.22 2.26 2.20 2.14
Latest Dividend: 0.61
Latest Dividend Yield: 1.91%
Dividend Ex-Date: 05/13/14
Price Earnings Ratio: 19.20
Price Earnings Comparisons:
AMGN Sector Avg. S&P 500
19.20 17.40 29.08
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-3.10% 5.50% 108.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.20 0.24 0.07
Net Income 16.90 0.10 0.03
EPS 20.30 0.40 0.12
Earnings for AMGN:
EBITDA 7.35B
Revenue 18.68B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $1.81 $1.96 $8.10 $8.80
Number of Analysts 3 3 3 3
High Estimate $1.83 $2.06 $8.15 $9.23
Low Estimate $1.78 $1.80 $8.05 $8.43
Prior Year $1.95 $1.88 $7.57 $8.10
Growth Rate (Year over Year) -7.01% 4.26% 7.05% 8.64%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bullish
Mar 28, 2014 | 8:08 AM EDT
Shares of AMGN reaching $145, Jefferies said. Driven by increased evolocumab sales estimates. $145 price target and Buy rating. 
Bullish
Mar 18, 2014 | 8:05 AM EDT
Shares of AMGN now seen reaching $155, according to Citigroup. Estimates also upped, given the prospects of the company's cholesterol d...
Update
Mar 03, 2014 | 6:57 AM EST
Cowen Health Care Conference (Day 1 of 3) - 03/03/14 - 03/05/14 Boston, MA
What that means for investors and policymakers alike.

Looking Ahead to Next Week Real Money Pro($)

Thanks for spending time with us today and have a great weekend.
Take a long, hard look at yourself -- and at the Fed.
These four names are soaring, and I'd jump into all of them, even after their recent runs.
Update
Nov 13, 2013 | 7:09 AM EST
Credit Suisse Healthcare Conference (Day 3 of 4) - 11/11/13 - 11/14/13 Phoenix, AZ
The market is richly priced right now, but you can still find bargains.
Bullish
Sep 24, 2013 | 8:04 AM EDT
Shares of AMGN now seen reaching $116, according to BMO Capital. Pipeline prospects continue to improve. Market Perform rating. 

Columnist Conversations

The new Fed Chief said this at a recent meeting of the Economic Club of NY ... "We have indeed had a disappoin...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.